Progress toward elimination of hepatitis B virus transmission in the United States
- PMID: 9915035
- DOI: 10.1016/s0264-410x(98)00294-1
Progress toward elimination of hepatitis B virus transmission in the United States
Abstract
The strategy to eliminate hepatitis B virus (HBV) transmission in the United States is comprised of the following components: (1) preventing perinatal transmission, (2) routine infant vaccination, (3) catch-up vaccination of children in high-risk groups at any age, (4) catch-up vaccination of all children at 11-12 years of age and (5) vaccination of adolescents and adults in high-risk groups. According to recent surveys, > 85% of pregnant women are screened for hepatitis B surface antigen (HBsAg). Of infants born to HBsAg-positive women identified in 1995, 93% received appropriate immunoprophylaxis at birth; however, only 69% were fully vaccinated by 6-8 months of age. From 1991 (when routine infant hepatitis B vaccination was first recommended) to 1996, the proportion of 19-35-month-old children who have received three doses of hepatitis B vaccine has increased from < 10 to 83%. During this time, rates of acute hepatitis B in children 7-10 years of age have declined by 27% and rates among children 3-6 years of age have declined by 62%. Implementation of programmes for catch-up vaccination of all adolescents at 11-12 years of age and for vaccination of adolescents and adults in high-risk groups have only recently begun and no data are available to assess the progress of these programmes. However, 26% (13/50) of states now have laws requiring adolescents to be vaccinated in order to enter school. Current data indicate that substantial progress has been made in implementing a strategy to eliminate HBV transmission in the United States. Future efforts need to be focused on improving complete immunoprophylaxis of infants of HBsAg-positive mothers, increasing vaccine coverage among 11-12 year old children and implementing programmes to vaccine adolescents and adults in high-risk groups.
Similar articles
-
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31. MMWR Recomm Rep. 2005. PMID: 16371945
-
Hepatitis B vaccination in children: the Taiwan experience.Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29. Pathol Biol (Paris). 2010. PMID: 20116181
-
Surveillance for acute viral hepatitis - United States, 2007.MMWR Surveill Summ. 2009 May 22;58(3):1-27. MMWR Surveill Summ. 2009. PMID: 19478727
-
Hepatitis B vaccination of adolescent and adult high-risk groups in the United States.Vaccine. 1998 Nov;16 Suppl:S27-9. doi: 10.1016/s0264-410x(98)00288-6. Vaccine. 1998. PMID: 9915029 Review.
-
Hepatitis B infection in Minnesota: a case for universal immunization.Pediatr Infect Dis J. 1998 Jul;17(7 Suppl):S30-4. doi: 10.1097/00006454-199807001-00003. Pediatr Infect Dis J. 1998. PMID: 9688097 Review.
Cited by
-
Clinical and Virological Features of Acute Hepatic Exacerbations in Patients With Chronic Hepatitis B Virus Infection.Cureus. 2021 Jun 26;13(6):e15937. doi: 10.7759/cureus.15937. Cureus. 2021. PMID: 34194888 Free PMC article.
-
The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.Hum Vaccin Immunother. 2015;11(5):1102-7. doi: 10.4161/21645515.2014.985500. Hum Vaccin Immunother. 2015. PMID: 25621975 Free PMC article. Clinical Trial.
-
Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults.Hum Vaccin Immunother. 2015;11(5):1108-13. doi: 10.4161/21645515.2014.988547. Hum Vaccin Immunother. 2015. PMID: 25607773 Free PMC article. Clinical Trial.
-
Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014 Dec. PLoS Med. 2014. PMID: 25549238 Free PMC article. Clinical Trial.
-
Multilevel factors influencing hepatitis B screening and vaccination among Vietnamese Americans in Atlanta, Georgia.Yale J Biol Med. 2014 Dec 12;87(4):455-71. eCollection 2014 Dec. Yale J Biol Med. 2014. PMID: 25506280 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical